SCHEMBL1678600

SCHEMBL1678600

CN(C)C1CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12036975 0.96 ADH1A (0.46)
Ammonia Solution, Strong SCHEMBL29080997 0.96
SCHEMBL284507 0.96
Hydrochloric Acid SCHEMBL313812 0.93
Ammonia Solution, Strong SCHEMBL2886635 0.93
SCHEMBL1674941 0.93 ADH1A (0.50)
SCHEMBL13356252 0.93 ADH1A (0.50)
SCHEMBL283931 0.93 ADH1A (0.50)
SCHEMBL20733112 0.93 ADH1A (0.50)
SCHEMBL1679002 0.93 ADH1A (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 212 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115043844-B TRK kinase inhibitor compounds and uses thereof 河南迈英诺医药科技有限公司 2024-05-17 CN claimed
CN-111819176-B 4-azaindole compounds 百时美施贵宝公司 2023-12-15 CN claimed
CN-111491930-B Substituted Indole Compounds Useful as TLR Inhibitors 百时美施贵宝公司 2023-09-26 CN claimed
CN-115043844-A TRK kinase inhibitor compounds and uses thereof 河南迈英诺医药科技有限公司 2022-09-13 CN claimed
CN-112912373-B Angiogenesis inhibitor, preparation method and application thereof 北京康辰药业股份有限公司 2022-08-23 CN claimed
CN-114835570-A Synthesis method of trans-1, 2-diaminomethyl-cyclobutane and salt thereof 上海寻科生物医药科技有限公司 2022-08-02 CN claimed
CN-113416150-B Synthetic method of lobaplatin intermediate 上海寻科生物医药科技有限公司 2022-05-31 CN claimed
CN-113416150-A Novel synthesis method of lobaplatin intermediate 上海寻科生物医药科技有限公司 2021-09-21 CN claimed
CN-112912373-A Angiogenesis inhibitor, preparation method and application thereof 北京康辰药业股份有限公司 2021-06-04 CN claimed
CN-112358469-A Angiogenesis inhibitor, preparation method and application thereof 北京康辰药业股份有限公司 2021-02-12 CN claimed
CN-111819176-A 4-azaindole compounds 百时美施贵宝公司 2020-10-23 CN claimed
CN-111491930-A Substituted indole compounds useful as T L R inhibitors 百时美施贵宝公司 2020-08-04 CN claimed
CN-108624884-B The PCB surface treating agent and surface treatment method for removing brownification layer and the outstanding copper of blind hole 昆山市板明电子科技有限公司 2019-08-27 CN claimed
CN-108624884-A The PCB surface conditioning agents and surface treatment method for removing brown layer and the outstanding copper of blind hole 昆山市板明电子科技有限公司 2018-10-09 CN claimed
CN-108047277-A The preparation method of liposoluble platinum complex with antitumor activity 昆明贵研药业有限公司 2018-05-18 CN claimed
CN-103663484-B Method for quickly synthesizing SAPO(silicoaluminophosphate)-34 molecular sieve and catalyst prepared from molecular sieve DALIAN CHEMICAL PHYSICS INST 2015-06-17 CN claimed
CN-103663484-A Method for quickly synthesizing SAPO(silicoaluminophosphate)-34 molecular sieve and catalyst prepared from molecular sieve DALIAN CHEMICAL PHYSICS INST 2014-03-26 CN claimed
EP-4739692-A1 SUBSTITUTED HEXAHYDRO-2H-PYRAZINO[1,2-A]PYRAZIN-1(6H)-ONE DERIVATIVES AS ACTIVATORS OF HUMAN CASEINOLYTIC PROTEASE P (HSCLPP) Centro Atlantico del Medicamento S.A (Ceamed, S.A) (ES) 2026-05-13 EP disclosed
WO-1980000537-A1 PYRIMIDO(1,6-A)INDOLE DERIVATIVES AMERICAN HOME PROD (US) 1980-04-03 WO disclosed
EP-0008950-A2 Pyrimido(1,6-a)indole derivatives and intermediates therefor, processes for their preparation, pharmaceutical compositions containing the derivatives and their use AMERICAN HOME PRODUCTS CORPORATION (US) 1980-03-19 EP disclosed